buprenorphine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TEMGESIC buprenorphine 300microgram/1mL (as hydrochloride) injection ampoule
AUST R: 15394
Active ingredients:
buprenorphine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Echo Therapeutics Pty Ltd

Phone:
1300 848 328

From
16 Aug 2021
to
31 Oct 2026

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Healthcare professionals to consider alternative treatment options.
SUBUTEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack
AUST R: 76661
Active ingredients:
buprenorphine hydrochloride

Dosage form:
Tablet

Sponsor:
Indivior Pty Ltd

Phone:
0290250200

Deletion from market:
31 Dec 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
The sponsor is closely controlling the supply. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
SUBUTEX buprenorphine 2mg (as hydrochloride) tablet blister pack
AUST R: 76662
Active ingredients:
buprenorphine hydrochloride

Dosage form:
Tablet

Sponsor:
Indivior Pty Ltd

Phone:
0290250200

Deletion from market:
31 Dec 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
The sponsor is closely controlling the supply. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
SUBUTEX buprenorphine 8mg (as hydrochloride) tablet blister pack
AUST R: 76663
Active ingredients:
buprenorphine hydrochloride

Dosage form:
Tablet

Sponsor:
Indivior Pty Ltd

Phone:
0290250200

Deletion from market:
31 Dec 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
The sponsor is closely controlling the supply. Patients are advised to consult their healthcare professional to discuss alternative treatment options.